Derivatives of acrylic acid (the structural formula CH2=CHCO2H), including its salts and esters.
DrugDrug NameDrug Description
DB01971trans-urocanic acidNot Available
DB04741MyxothiazolNot Available
DB05112AP5280Investigated for use/treatment in solid tumors.
DB07778FAMOXADONENot Available
DB09330OsimertinibA tyrosine kinase inhibitor used in the treatment of certain types of non-small cell lung carcinoma.
DB11764SpebrutinibSpebrutinib has been used in trials studying the treatment of Rheumatoid Arthritis, Lymphoma, Large B-Cell, Diffuse, and Leukemia Lymphocytic Chronic B-Cell.
DB11907RociletinibRociletinib has been used in trials studying the treatment and prevention of Nonsmall Cell Lung Cancer, Non-small Cell Lung Cancer, and Locally Advanced or Metastatic Non-small Cell Lung Cancer.
DB12017OzagrelOzagrel has been used in trials studying the treatment of Dry Eye Syndromes.
DB120402-octyl cyanoacrylateDermabond has been investigated for the basic science of Wound Healing.
DB12207VerdinexorKpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).
DB12358EnbucrilateEnbucrilate is under investigation in clinical trial NCT02468206 (Secondary Prophylaxis of Gastric Variceal Bleed).
DB12428PAC-14028PAC-14028 has been used in trials studying the treatment of Skin Pruritus, Papulopustular Rosacea, and Erythematotelangiectatic Rosacea.
DB12731DaporinadDaporinad has been used in trials studying the treatment of Melanoma, Cutaneous T-cell Lymphoma, and B-cell Chronic Lymphocytic Leukemia.
DB13054ACT-451840ACT-451840 has been used in trials studying Malaria.
DB14993PyrotinibPyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).
DB15086OcrylateOcrylate is under investigation in clinical trial NCT01918059 (Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive).